KEGG   COMPOUND: C00533
Entry
C00533                      Compound                               
Name
Nitric oxide;
NO;
Nitrogen monoxide
Formula
NO
Exact mass
29.998
Mol weight
30.0061
Structure
Remark
Same as: D00074
Reaction
R00111 R00280 R00294 R00557 R00783 R00784 R00785 R02492
R05724 R05725 R09445 R09446 R09751 R09799 R09808 R09809
R09996 R10106 R10108 R10165 R11711 R11713
Pathway
map00330  Arginine and proline metabolism
map00910  Nitrogen metabolism
map01100  Metabolic pathways
map01120  Microbial metabolism in diverse environments
map04022  cGMP-PKG signaling pathway
map04066  HIF-1 signaling pathway
map04071  Sphingolipid signaling pathway
map04151  PI3K-Akt signaling pathway
map04270  Vascular smooth muscle contraction
map04370  VEGF signaling pathway
map04371  Apelin signaling pathway
map04540  Gap junction
map04611  Platelet activation
map04621  NOD-like receptor signaling pathway
map04626  Plant-pathogen interaction
map04713  Circadian entrainment
map04730  Long-term depression
map04915  Estrogen signaling pathway
map04921  Oxytocin signaling pathway
map04924  Renin secretion
map04926  Relaxin signaling pathway
map04931  Insulin resistance
map04940  Type I diabetes mellitus
map04970  Salivary secretion
map05010  Alzheimer disease
map05014  Amyotrophic lateral sclerosis
map05022  Pathways of neurodegeneration - multiple diseases
map05140  Leishmaniasis
map05142  Chagas disease
map05143  African trypanosomiasis
map05144  Malaria
map05146  Amoebiasis
map05171  Coronavirus disease - COVID-19
map05200  Pathways in cancer
map05225  Hepatocellular carcinoma
map05330  Allograft rejection
map05332  Graft-versus-host disease
map05415  Diabetic cardiomyopathy
map05418  Fluid shear stress and atherosclerosis
Module
M00529  Denitrification, nitrate => nitrogen
Network
nt06226  KEAP1-NRF2 signaling
nt06263  Hepatocellular carcinoma
nt06463  Parkinson disease
nt06521  NLR signaling
Enzyme
1.7.1.14        1.7.2.1         1.7.2.5         1.7.2.7         
1.7.2.9         1.7.5.2         1.7.6.1         1.14.12.17      
1.14.13.39      1.14.14.47
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 R RESPIRATORY SYSTEM
  R07 OTHER RESPIRATORY SYSTEM PRODUCTS
   R07A OTHER RESPIRATORY SYSTEM PRODUCTS
    R07AX Other respiratory system products
     R07AX01 Nitric oxide
      D00074  Nitric oxide (JAN/USAN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  21  Cardiovascular agents
   219  Miscellaneous
    2190  Miscellaneous
     D00074  Nitric oxide (JAN/USAN)
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D00074
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D00074
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D00074
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D00074
Other DBs
CAS: 10102-43-9
PubChem: 3815
ChEBI: 16480
3DMET: B00122
NIKKAJI: J161.349I
LinkDB
KCF data

ATOM        2
            1   O3a O    21.4046  -16.1648
            2   N2a N    22.8046  -16.1648 #^
BOND        1
            1     1   2 2

» Japanese version

DBGET integrated database retrieval system